Displaying One Session

Salamanca Auditorium (Hall 3) Proffered Paper session
Date
30.09.2019
Time
16:30 - 18:00
Location
Salamanca Auditorium (Hall 3)
Chairs
  • E.G. Elisabeth De Vries (Groningen, Netherlands)
  • William K. Evans (Hamilton, Ontario, Canada)
Proffered Paper session Proffered Paper session

1626O - ESMO-MCBS and Health Technology Assessment (HTA): Does value for physicians correspond to value for payers? (ID 5276)

Presentation Number
1626O
Lecture Time
16:30 - 16:42
Speakers
  • Apoorva Ambavane (Dubai, United Arab Emirates)
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
16:30 - 18:00
Proffered Paper session Proffered Paper session

1627O - Change in Magnitude of Clinical Benefit, Overall Survival (OS) and Quality of Life (QoL) between time of approval and post-marketing among cancer drugs approved by the US Food and Drug Administration (FDA) 2006-2015. (ID 2243)

Presentation Number
1627O
Lecture Time
16:42 - 16:54
Speakers
  • Aida Bujosa Rodríguez (Barcelona, Spain)
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
16:30 - 18:00
Proffered Paper session Proffered Paper session

1628O - Consistency of ESMO-MCBS scores with drug access recommendations in Catalonia (ID 5379)

Presentation Number
1628O
Lecture Time
16:54 - 17:06
Speakers
  • Carlota Salazar (Barcelona, Spain)
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
16:30 - 18:00
Proffered Paper session Proffered Paper session

Invited Discussant 1626O, 1627O and 1628O (ID 7129)

Lecture Time
17:06 - 17:21
Speakers
  • E.G. Elisabeth De Vries (Groningen, Netherlands)
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
16:30 - 18:00
Proffered Paper session Proffered Paper session

1629O_PR - The price of added value for new anti-cancer drugs in France 2004-17 (ID 5174)

Presentation Number
1629O_PR
Lecture Time
17:21 - 17:33
Speakers
  • Patricia Marino (Marseille, France)
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
16:30 - 18:00
Proffered Paper session Proffered Paper session

1630O - Reimbursement Reality for Off-label use in cancer care – A systematic empirical investigation (ID 3815)

Presentation Number
1630O
Lecture Time
17:33 - 17:45
Speakers
  • Amanda K. Herbrand (Basel, Switzerland)
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
16:30 - 18:00
Proffered Paper session Proffered Paper session

Invited Discussant 1629O_PR and 1630O (ID 7130)

Lecture Time
17:45 - 18:00
Speakers
  • Bengt Jönsson (Stockholm, Sweden)
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
16:30 - 18:00